Cationic Phosphorus Dendrimer Enhances Photodynamic Activity of

Mar 28, 2017 - After harvesting, cells were counted using trypan blue exclusion assay for further experiments (Countess Automated Cell Counter, Invitr...
0 downloads 0 Views 3MB Size
Subscriber access provided by STEPHEN F AUSTIN STATE UNIV

Article

Cationic phosphorus dendrimer enhances photodynamic activity of rose bengal against basal cell carcinoma cell lines Monika Dabrzalska, Anna Janaszewska, Maria Zablocka, Serge Mignani, Jean Pierre Majoral, and Barbara Klajnert-Maculewicz Mol. Pharmaceutics, Just Accepted Manuscript • DOI: 10.1021/acs.molpharmaceut.7b00108 • Publication Date (Web): 28 Mar 2017 Downloaded from http://pubs.acs.org on March 31, 2017

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

Molecular Pharmaceutics is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Molecular Pharmaceutics

1

Cationic

phosphorus

dendrimer

enhances

2

photodynamic activity of rose bengal against basal

3

cell carcinoma cell lines

4

Monika Dabrzalska1, Anna Janaszewska1, Maria Zablocka2, Serge Mignani3, Jean Pierre

5

Majoral4,5, Barbara Klajnert-Maculewicz1,6*

6

1

7

University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland

8

2

9

112, 90-363 Lodz, Poland

Department of General Biophysics, Faculty of Biology and Environmental Protection,

Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza

10

3

11

Chimie et de Biochimie pharmacologiques et toxicologique, 45 rue des Saints Pères, 75006

12

Paris, France

13

4

Laboratoire de Chimie de Coordination CNRS, 205 route de Narbonne, 31077 Toulouse, France

14

5

Université de Toulouse, UPS, INPT, 31077, Toulouse Cedex 4, France

15

6

Leibniz-Institut für Polymerforschung Dresden e.V., Hohe Strasse 6, 01069 Dresden, Germany

16

* Corresponding author: Barbara Klajnert-Maculewicz, email: [email protected]

Université Paris Descartes, PRES Sorbonne Paris Cité, CNRS UMR 860, Laboratoire de

ACS Paragon Plus Environment

1

Molecular Pharmaceutics

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 2 of 45

17

KEYWORDS: phosphorus dendrimer, rose bengal, photosensitizer, photodynamic therapy,

18

basal cell carcinoma, phototoxicity.

19

ABSTRACT

20

In the last couple of decades, photodynamic therapy emerged as a useful tool in the treatment of

21

basal cell carcinoma. However, it still meets limitations due to unfavorable properties of

22

photosensitizers, such as poor solubility or lack of selectivity. Dendrimers - polymers widely

23

studied in biomedical field - may play a role as photosensitizer carriers and improve the efficacy

24

of photodynamic treatment. Here, we describe the evaluation of an electrostatic complex of

25

cationic phosphorus dendrimer and rose bengal in such aspects as singlet oxygen production,

26

cellular uptake and phototoxicity against three basal cell carcinoma cell lines. Rose bengal-

27

cationic dendrimer complex in molar ratio 5:1 was compared to free rose bengal. Obtained

28

results showed that the singlet oxygen production in aqueous medium was significantly higher

29

for the complex than for free rose bengal. The cellular uptake of the complex was 2-7-fold higher

30

compared to a free photosensitizer. Importantly, rose bengal, rose bengal-dendrimer complex and

31

dendrimer itself showed no dark toxicity against all three cell lines. Moreover, we observed that

32

phototoxicity of the complex was remarkably enhanced presumably due to high cellular uptake.

33

Based on the obtained results we conclude that rose bengal-cationic dendrimer complex has a

34

potential in photodynamic treatment of basal cell carcinoma.

35

36 37

ACS Paragon Plus Environment

2

Page 3 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

38

Molecular Pharmaceutics

1. INTRODUCTION

39

Basal cell carcinoma (BCC) is currently the most common type of skin cancer and has the

40

highest incidence among all type of cancers in Caucasians.1 The treatment of BCC cancer

41

is often based on surgical excision, although other therapies, such as photodynamic therapy

42

(PDT), may be applied as well.2 As PDT is rather a topical treatment method, it seems to be a

43

useful tool to treat topical diseases such as skin cancer, especially BCC tumors characterized by

44

very low rate of metastasis. Particularly, PDT offers excellent cosmetic outcomes.3-5

45

Photodynamic therapy has emerged as a treatment method nearly 40 years ago. This approach

46

is based on three elements: a photosensitizer (PS), molecular oxygen and visible light. The

47

mechanism of a photodynamic effect relies on a photosensitizer, which absorbs the energy after

48

illumination with a specific wavelength of visible light. This cause the excitation of PS from

49

the ground state (S0) to the first excited singlet state (S1). The excited photosensitizer can lose

50

the energy by fluorescence emission, conversion into heat or via intersystem crossing forming

51

long-lived excited triplet state (T1). A photosensitizer in an excited triplet state can react with

52

other molecules via two types of reactions. A Type I mechanism is based on reactions of

53

photosensitizer with surrounding substrates producing radicals and reactive oxygen species

54

(ROS). A Type II mechanism involves direct energy transfer between photosensitizer and the

55

molecular oxygen in ground state generating highly reactive singlet oxygen. Both types of

56

reactions lead to the oxidative stress and a cascade of reactions that ultimately cause cell death

57

(Scheme 1).6

ACS Paragon Plus Environment

3

Molecular Pharmaceutics

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 4 of 45

58 59

Scheme 1. Schematic representation of PDT mechanisms.

60

Although many compounds have been identified as photoactive, there are still few

61

photosensitizers approved in clinics. Unfortunately, the photodynamic therapy has a number of

62

limitations including poor PS solubility, lack of selectivity and prolonged sensitivity to light.

63

Hence, there is a need to improve the efficacy of photodynamic treatment.7 The challenge may

64

be achieved by designing drug delivery systems for photosensitizers to overcome above

65

mentioned disadvantages. Many different nanoparticles have been proposed as PS delivery

66

systems, e.g. liposomes,8,9 polymeric nanoparticles10 or silica nanoparticles.11 Among many

67

types of nanosystems, dendrimers have been proven to be promising platforms for drug delivery,

68

especially because of their regular, hyperbranched architecture, which specifically enables

69

several different ways to attach drug molecules to a carrier.12-14 PS molecules can be attached

70

either to the internal or surface groups. In addition, PS can be located at the core of the

ACS Paragon Plus Environment

4

Page 5 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Molecular Pharmaceutics

71

dendrimer, or it is possible to encapsulate PS molecules in internal cavities between dendrimer

72

branches.15 The majority of the studies on dendrimers as carriers of photosensitizers involved

73

porphyrins and phthalocyanines,16-20 and in one case authors demonstrated enhanced PDT

74

efficacy in vivo in comparison to clinically used PS –Photofrin®.21

75

Dendrimers may also deliver hydrophilic photosensitizers, such as 5-aminolewulinic acid (5-

76

ALA)22 or rose bengal.23 Rose bengal is a xanthene dye exhibiting high quantum yield of singlet

77

oxygen generation.24,25 It is a hydrophilic molecule with tendency to aggregate in aqueous

78

solutions. Therefore, the cellular uptake of rose bengal is often suppressed.26,27 It has a negative

79

impact on the reactive oxygen species generation and a cytotoxic effect caused by rose bengal.

80

Complexing rose bengal molecules with a dendrimer may significantly prevent the aggregation

81

of PS molecules. Moreover, an effective delivery of rose bengal through the cell membrane may

82

be enhanced by the use of a dendrimer as a nanocarrier of rose bengal molecules.

83

Recently we have prepared and characterized a dendrimer-photosensitizer complex using a

84

phosphorus dendrimer possessing cationic charges (1cat) and rose bengal (RB). Studies on the

85

interactions between RB and 1cat using Fourier transform infrared spectroscopy (FTIR)

86

demonstrated that 1cat formed a stable complex with RB molecules due to electrostatic

87

interactions. The stoichiometry of the complex RB:1cat was determined to be approximately 7:1.

88

We concluded that the cationic phosphorus dendrimer might be a promising candidate as a

89

carrier for RB.28,29 Therefore, it encouraged us to further investigation of the system in vitro.

90

The objective of this present study was to evaluate photodynamic activity of RB-1cat

91

dendrimer complex. We checked the ability of the complex to produce singlet oxygen in aqueous

92

environment and we compared a cellular uptake and phototoxicity of a free photosensitizer and

93

of the RB-1cat complex. As a biological model for the studies, we chose basal cell carcinoma

ACS Paragon Plus Environment

5

Molecular Pharmaceutics

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 6 of 45

94

cell lines. We used three long-term, murine basal cell carcinoma cell lines (ASZ, BSZ and CSZ)

95

that resemble the genetic features of human basal cell nevus syndrome and basal cell carcinoma

96

tumors.30

97

2. EXPERIMENTAL SECTION

98

2.1. Materials

99

Phosphorus dendrimer of the third generation possessing 48 ammonium surface groups

100

(referred as 1cat) was synthesized in the Laboratoire de Chimie de Coordination du CNRS.31

101

Rose bengal, Fetal Bovine Serum, Penicillin-Streptomycin solution, Trypsin-EDTA solution and

102

MTT (3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) were purchased from

103

Sigma-Aldrich. Dulbecco’s Phosphate Buffered Saline with no calcium and no magnesium

104

(DPBS) was purchased from Biowest. 154 CF culture medium was obtained from Gibco®.

105

Chelex® 100 Resin was obtained from Bio-Rad. Singlet Oxygen Sensor Green (SOSG) and

106

2’,7’- dichlorodihydrofluorescein diacetate (H2DCFDA) were purchased from Molecular

107

Probes™. SYTOX® Dead Cell Stain Kit and Trypan Blue Stain were obtained from

108

Invitrogen™. Dimethyl Sulphoxide (DMSO) was purchased from POCH (Poland). Annexin V-

109

fluorescein isothiocyanate (FITC) and binding buffer were obtained from BD Biosciences. The

110

structure of rose bengal (RB), 1cat dendrimer and schematic structure of the dendrimer is

111

depicted in Scheme 2.

ACS Paragon Plus Environment

6

Page 7 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Molecular Pharmaceutics

112 113

Scheme 2. Structures of the components used in this study: a) chemical structure of rose bengal

114

(RB); b) schematic structure of the cationic phosphorus dendrimer of third generation (1cat); c)

115

chemical structure of 1cat dendrimer.

116

2.2. Methods

117

2.2.1. Singlet Oxygen (1O2) generation in aqueous medium

118

To determine singlet oxygen production we used Singlet Oxygen Sensor Green reagent

119

(SOSG). SOSG is a commercially available, cell impermeable, fluorescent probe that is highly

120

selective for 1O2. SOSG was used in 1 µM concentration. All solutions of RB and RB-1cat

121

complex and 1cat were prepared in 10 mM DPBS buffer. Three concentrations of RB were used:

122

0.1, 0.25 and 0.5 µM. A molar ratio RB:1cat was 5:1. Respectively, the dendrimer concentrations

123

in a complex were 0.02, 0.05 and 0.1 µM. After sample preparation, 100 uL of solutions were

124

transferred into 96-well black plate. All measurements were recorded with fluorescence

ACS Paragon Plus Environment

7

Molecular Pharmaceutics

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 8 of 45

125

microplate reader (Fluoroscan Ascent FL). The excitation wavelength was 500 nm and the

126

excitation wavelength was 538 nm. Samples were shaken prior to every measurement. The first

127

measurement was recorded with no SOSG probe in order to determine whether RB or RB-1cat

128

emits fluorescence in this region. Both, RB and RB-1cat did not show any emission upon

129

excitation at 500 nm. Following the first measurement, SOSG was added to each well and the

130

fluorescence of SOSG without irradiation was checked. Next, the plate were immediately placed

131

under the Q.Light Pro Unit lamp equipped with a filter emitting visible light from 385 nm to 780

132

nm. All samples were irradiated and the fluorescence was measured in the course of irradiation

133

time, from 1 to 60 minutes.

134

2.2.2. Cell culture

135

Three murine basal cell carcinoma lines were kindly provided by Dr. Ervin Epstein (Children’s

136

Oakland Research Institute). ASZ, BSZ and CSZ cells were cultured in 154-CF mediumwith

137

antibiotics, 0.05 mM calcium and 2% chelexed, heat-inactivated FBS. Cells were maintained at

138

37°C in a humidified incubator and under a 5% CO2 atmosphere. After harvesting, cells were

139

counted using trypan blue exclusion assay for further experiments (Countess Automated Cell

140

Counter, Invitrogen). For harvesting the cells a 0.25% (w/v) trypsin–0.03% (w/v) EDTA solution

141

was used.

142

2.2.3. Cellular uptake

143

ASZ, BSZ and CSZ cell lines were seeded in 24-well plates and incubated for 24 hours in a

144

humified incubator under 5% CO2 atmosphere. Next, RB (10 µM) and RB-1cat were added to

145

the cells in 154 CF medium. The cells were incubated with the compounds up to 7 hours.

146

Following the incubation the compounds were discarded and cells were washed with DPBS

147

buffer. Next, the cells were detached using Trypsin-EDTA solution. Then, fresh culture medium

ACS Paragon Plus Environment

8

Page 9 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Molecular Pharmaceutics

148

was added to the cells and the samples were gently mixed and collected for measurements. For

149

estimating the cellular uptake, the fluorescence of the samples was measured using flow

150

cytometry (LSRII, Becton Dickinson). The excitation and the emission filters were 520 nm and

151

570 nm, respectively.

152

2.2.4. Photodynamic activity of RB and RB-1cat complex in vitro

153

To measure cytotoxicity cells were seeded in 96-well plates at density 3 × 104 cells well−1.

154

After 24h incubation, the culture medium was aspirated from the wells. Then, 100 µL of free

155

photosensitizer (RB) or complex (RB-1cat) were added to the cells. All components were

156

prepared in fresh culture medium. RB was used at concentrations of 0.1, 0.25, 0.5 and 0.75 µM.

157

The molar ratio RB:1cat was 5:1, therefore the dendrimer was used at concentrations of 0.02,

158

0.05, 0.1 and 0.15 µM. The control cells were untreated, instead fresh culture medium was

159

added. Cells were incubated with components for 5 hours in 37°C. Then, the medium containing

160

tested components was replaced with fresh DPBS buffer and cells were irradiated with visible

161

light using a lamp emitting broad spectrum light equipped with a filter (Q.Light Pro Unit,

162

Q.Products AG, Switzerland). The filter used for photosensitizing RB emits visible light from

163

385 nm to 780 nm. The time of irradiation was 30 minutes. Immediately after irradiation DPBS

164

buffer was replaced with fresh culture medium and cells were incubated for 24 hours as post

165

PDT incubation. Then, cell viability was measured using MTT assay. MTT was added to the

166

wells at a concentration of 0.5 mg/mL and incubated in 37°C for 3 hours. The formazan crystals

167

were dissolved with DMSO and the absorbance was read at 570 nm on the PowerWave HT

168

Microplate Spectrophotometer (BioTek, USA). Also, the dark toxicity (without irradiation) of

169

RB, RB-1cat and 1cat was checked. The protocol of these experiments was identical but in this

170

case cells were not irradiated.

ACS Paragon Plus Environment

9

Molecular Pharmaceutics

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 10 of 45

171

2.2.5. Detection of apoptotic and necrotic cells after the irradiation

172

Annexin V-Fluorescein Isothiocyanate (FITC)/Sytox staining was used to determine apoptotic

173

and necrotic cells. The double staining method allows detecting apoptotic cells in which

174

phosphatydylserine is translocated to outer layer of the plasma membrane. Annexin V possesses

175

high affinity to phosphatydylserine. Apoptotic cells stained with Annexin V-FITC exclude

176

Sytox, and necrotic cells are permeable to Sytox. Thus, the double staining allows differentiating

177

between viable, apoptotic and necrotic cell populations. Cells were seeded in 12-well plates at

178

the density of 2.5 x 105 cells/well and incubated for 24 hours. Then, RB and RB-1cat were

179

added. The concentration of RB and 1cat was 0.25 µM and 0.05 µM, respectively. After 5 hours

180

incubation, cells were irradiated as it was described in the previous experiments. Next, cells were

181

washed with DPBS, detached and centrifuged at 2500 rpm. Then cells were suspended in 200 µL

182

of binding buffer (delivered by the producer) containing 4 µL of Annexin V-FITC and 0.2 µL of

183

Sytox. Samples were incubated for 15 min at 4°C in dark. Fluorescence intensity was measured

184

with a Becton Dickinson LSR II flow cytometer. Apoptotic and necrotic cells were used as

185

compensation controls. Apoptosis was induced using 80 µM camptothecin and necrosis was

186

induced using frozen ethanol (data not shown).

187

2.2.6. Reactive oxygen species

188

We used H2DCFDA molecular probe (2’, 7’- dichlorodihydrofluorescein diacetate, Molecular

189

Probes™) in order to investigate the intracellular production of ROS. Cells were seeded in 96-

190

well plates at density 3 × 104 cells well−1and solutions of RB, RB1-cat and 1cat were added. The

191

concentration of free and complexated RB was 0.25 µM and 1cat concentration was 0.05 µM.

192

DPBS was used as a control. Cells were incubated with components for 5 hours at 37°C in a

193

humified atmosphere containing 5% CO2. After washing the cells with DPBS, solution of 2 µM

ACS Paragon Plus Environment

10

Page 11 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Molecular Pharmaceutics

194

H2DCFDA in DPBS was added to each wells and plates were incubated for 15 min in dark.

195

Next, the cells were washed with DPBS and 100 µL of DPBS was added. 485/530 nm

196

fluorescence of DCF was measured as a background using BIOTEK PowerWave HT Microplate

197

reader (Biotek). Then cells were irradiated for 30 min and the fluorescence was measured

198

immediately after irradiation. Every measurement was corrected by subtraction of the

199

background fluorescence intensity.

200

2.2.7. Statistical analysis

201

Statistical analysis was performed using Sigma Plot version 12.5 (Systat Software, USA).

202

Results are presented as a mean ± SD of three independent experiments. One-way analysis of

203

variance (ANOVA) was used for testing statistical differences between groups followed by post-

204

hoc Tukey test. A P-value of